Ameritas Investment Partners, Inc. Aptinyx Inc. Transaction History

Ameritas Investment Partners, Inc.

  • $2.98 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$2.39 - $3.5 $5,183 - $7,591
-2,169 Closed
0 $0
Q2 2020

Aug 05, 2020
BUY
$1.99 - $4.4 $4,316 - $9,543
2,169 New
2,169 $9,000
Q2 2019

Aug 14, 2019
SELL
$2.95 - $4.38 $3,236 - $4,804
-1,097 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$20.21 - $31.85 $22,170 - $34,939
1,097 New
1,097 $32,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email